Sarcoidosis Advocate Appointed Patient Advisor at aTyr

Sarcoidosis Advocate Appointed Patient Advisor at aTyr

291570

Sarcoidosis Advocate Appointed Patient Advisor at aTyr

aTyr Pharma, which is developing a candidate therapy for pulmonary sarcoidosis called ATYR1923, has appointed Andrea Wilson — a sarcoidosis patient and advocate who co-founded the Foundation for Sarcoidosis Research (FSR) — as a patient advisor. “We are pleased during Sarcoidosis Awareness Month to welcome Andrea, a leading advocate for sarcoidosis, as a patient advisor to aTyr,” said Sanjay S. Shukla, MD, aTyr’s president and CEO, said in a press release. “Andrea has dedicated the past…

You must be logged in to read/download the full post.